Zealand Pharma

Performance

About Zealand Pharma

Zealand Pharma is an international biotechnology company based in Denmark with operations in Boston, USA, focused on discovering, designing, and developing innovative peptide-based medicines and small molecule therapies that address unmet medical needs. The company concentrates on metabolic health and diseases where peptide therapeutics can transform outcomes, including obesity, congenital hyperinsulinism, short bowel syndrome, and chronic inflammation. Zealand aims to build a leading metabolic health pipeline with a portfolio of differentiated candidates and a commitment to advancing patient care globally. Its activities span research, development, and collaborations to bring novel treatments to patients in both Europe and North America.